ABSTRACT
In their 2012 guidelines for cervical cancer screening, several organizations call for less-frequent but more-effective screening that incorporates testing for human papillomavirus (HPV). We review these recommendations and the possible future direction of screening.
Footnotes
↵* Dr. Jin has disclosed that he is on the speaker’s bureaus of Merck and Qiagen.
- Copyright © 2013 The Cleveland Clinic Foundation. All Rights Reserved.
